IN2014DN10385A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10385A
IN2014DN10385A IN10385DEN2014A IN2014DN10385A IN 2014DN10385 A IN2014DN10385 A IN 2014DN10385A IN 10385DEN2014 A IN10385DEN2014 A IN 10385DEN2014A IN 2014DN10385 A IN2014DN10385 A IN 2014DN10385A
Authority
IN
India
Prior art keywords
agent
effervescent
acid
dosage form
chewable dosage
Prior art date
Application number
Other languages
English (en)
Inventor
MarkEdward STELLA
John Richard Entwisle
Jason William Newlon
Christine Louie Naykki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IN2014DN10385A publication Critical patent/IN2014DN10385A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036Silicones; Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
IN10385DEN2014 2012-06-12 2013-06-12 IN2014DN10385A (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261658430P 2012-06-12 2012-06-12
PCT/US2013/045303 WO2013188483A1 (en) 2012-06-12 2013-06-12 Effervescent dosage form

Publications (1)

Publication Number Publication Date
IN2014DN10385A true IN2014DN10385A (el) 2015-08-14

Family

ID=48672843

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10385DEN2014 IN2014DN10385A (el) 2012-06-12 2013-06-12

Country Status (12)

Country Link
US (1) US10617714B2 (el)
EP (1) EP2734192B1 (el)
CN (1) CN104363897A (el)
AU (1) AU2013274378B2 (el)
BR (1) BR112014030680B1 (el)
CA (1) CA2876062C (el)
ES (1) ES2541723T3 (el)
IN (1) IN2014DN10385A (el)
MX (1) MX368363B (el)
PL (1) PL2734192T3 (el)
RU (1) RU2014149581A (el)
WO (1) WO2013188483A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604124A1 (en) * 2011-12-16 2013-06-19 Nestec S.A. Soluble non-dairy creamer tablet surface-treated with carbohydrate
AU2016285446A1 (en) * 2015-06-29 2018-01-18 Elc Management Llc Particles with cross-linked coatings for cosmetic applications
CN107114795A (zh) * 2017-07-06 2017-09-01 胥永贵 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用
US11793876B2 (en) 2019-10-18 2023-10-24 L. Perrigo Company Bulk polyethylene glycol compositions
WO2022060310A1 (en) * 2020-09-18 2022-03-24 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising calcium carbonate, magnesium carbonat and simethicone
BR112023026531A2 (pt) * 2021-06-17 2024-03-05 Ocean Spray Cranberries Inc Açúcares raros em alimentos e bebidas
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1518364A (en) 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4396604A (en) 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
GB2148117B (en) 1983-09-28 1987-10-21 Gergely Gerhard An effervescent composition suitable for effervescent tablets
US4650669A (en) 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5073384A (en) 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
DE59203732D1 (de) 1991-07-01 1995-10-26 Gergely Gerhard Lutsch- oder Kautablette.
AU4597293A (en) 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
FR2705966B1 (fr) 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
AU6734096A (en) 1995-07-31 1997-02-26 Gerhard Gergely Chewing tablets with an effervescent action
CA2204599A1 (en) 1995-09-07 1997-03-13 Otsuka Pharmaceutical Co., Ltd. Low-pressure tableted effervescent preparation
US5807577A (en) 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5888544A (en) 1996-06-20 1999-03-30 Gerhard Gergely Effervescent system for effervescent tablets and effervescent granules
DE19814256A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
DE19859231A1 (de) 1998-12-21 2000-06-29 Kurt Heinz Bauer Schäumende Antacida-Suspensionstabletten
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US20030235613A1 (en) 2002-06-19 2003-12-25 Cts Chemical Industries Ltd. Popping oral administration form
US20040223921A1 (en) 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US20050074489A1 (en) 2003-10-01 2005-04-07 Pediamed Pharmaceuticals, Inc. Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof
ITMI20040242U1 (it) 2004-05-24 2004-08-24 Istituto Pirri S R L Contenitore per compresse effervescenti
US20060078509A1 (en) 2004-10-13 2006-04-13 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
EP2189154A1 (en) 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
CN101966165B (zh) 2009-07-14 2012-06-13 无锡健而乐医药科技有限公司 口腔吸收固体泡腾制剂
WO2011113965A1 (es) 2010-03-18 2011-09-22 Farmalider, S.A. Composición farmacéutica en forma sólida que contiene isoflavonas, una sal de calcio y vitamina d3
CN102232967A (zh) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 一种新型口服补钙泡腾剂及其制备方法
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form

Also Published As

Publication number Publication date
AU2013274378A1 (en) 2015-01-15
PL2734192T3 (pl) 2015-09-30
BR112014030680A2 (pt) 2017-06-27
WO2013188483A1 (en) 2013-12-19
US10617714B2 (en) 2020-04-14
MX368363B (es) 2019-09-30
CA2876062A1 (en) 2013-12-19
CN104363897A (zh) 2015-02-18
EP2734192B1 (en) 2015-04-15
US20190262392A1 (en) 2019-08-29
AU2013274378B2 (en) 2016-06-02
EP2734192A1 (en) 2014-05-28
BR112014030680B1 (pt) 2022-08-30
CA2876062C (en) 2017-09-12
ES2541723T3 (es) 2015-07-24
MX2014015253A (es) 2015-03-05
RU2014149581A (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
IN2014DN10385A (el)
PH12015501070A1 (en) Surfactant systems for zinc containing compositions
PH12014501213A1 (en) Aqueous oral care compositions
MX367210B (es) Soluciones orales estables para api combinados.
GB201215159D0 (en) Composition
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
MX350570B (es) Composiciones para cuidado oral que comprenden carbonato de calcio y un sistema conservador basado en alcohol bencílico o ácido benzoico, y un alquilen glicol.
MX361005B (es) Composiciones dentifricas que tienen conservantes optimizados.
EP2892348A4 (en) DISINFECTANT FORMULATION COMPRISING CALCIUM HYDROXIDE AND SODIUM HYPOCHLORITE
MX2017009659A (es) Composiciones que contienen arsenico y su uso en metodos de tratamiento.
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
MX2017007622A (es) Composiciones para el cuidado bucal.
PH12017501603A1 (en) Solid oral care composition
PH12015501722A1 (en) Solid dispersion comprising amorphous cilostazol
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
TR201005241A1 (tr) Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
MX2008015058A (es) Formulaciones de sal de prednisolona.
AR086153A1 (es) Aditivo para pre-enjuague final de maquinas lavadoras de botellas
RO130486A8 (ro) Formulă farmaceutică pentru comprimate masticabile mentolate cu calciu şi vitamina d3
UA81930U (en) Insectoacaricide "preparation 30b (m)"
PH22015000589U1 (en) Effervescent multivitamin tablet